和美药业 Delays Hong Kong Global Offering and Listing
和美药业 said it has decided to delay its global offering and listing in Hong Kong, citing current market conditions.
Related stories
Autohome Q3 Revenue Fell 26% to RMB1,315.0M
Autohome reported Q3 2026 revenue of RMB1,315.0M, down from RMB1,778.1M a year earlier. Net income attributable to the company was RMB195.0M versus RMB436.6M. Its board approved an
M impact | EQUITY | Nov 04, 2026, 09:43 AM UTC
Autohome Reports Q3 Operating Profit of RMB 95.7 Million
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
European session market picture: S&P 500 +0.47%, Nasdaq 100 +0.35%; EUR/USD +0.6%, WTI -0.59%, LLOY leads volume
European session market picture. US index futures: S and P futures is up 0.47 percent, Nasdaq futures is up 0.35 percent, Dow futures is up 0.96 percent and Russell futures is up 1
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
Autohome Announces Unaudited Third-Quarter 2026 Results
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
Autohome Reports Q3 Revenue of RMB 1,315 Million
M impact | EQUITY | Nov 04, 2026, 09:30 AM UTC
AudioCodes reports Q3 results, revenue rises 4.2%
AudioCodes reported Q3 non-GAAP EPS of $0.16, matching FactSet consensus. Revenue increased 4.2% year over year to $64.
M impact | EQUITY | Nov 04, 2026, 09:29 AM UTC